Literature DB >> 22307471

Vessel health and preservation (Part 1): a new evidence-based approach to vascular access selection and management.

Nancy L Moureau1, Nancy Trick, Thomas Nifong, Cathy Perry, Cheryl Kelley, Ruth Carrico, Michael Leavitt, Steven M Gordon, Jessica Wallace, Monte Harvill, Connie Biggar, Michael Doll, Loreli Papke, Lori Benton, Deborah A Phelan.   

Abstract

Vascular access for the infusion of medications and solutions requires timely assessment, planning, insertion, and assessment. Traditional vascular access is reactive, painful, and ineffective, often resulting in the exhaustion of peripheral veins prior to consideration of other access options. Evidence suggests clinical pathways improve outcomes by reducing variations and establishing processes to assess and coordinate care, minimizing fragmentation and cost. Implementation of a vascular access clinical pathway leads to the intentional selection of the best vascular access device for the patient specific to the individual diagnosis, treatment plan, current medical condition, and the patient's vessel health (1). The Vessel Health and Preservation (VHP) programme incorporates evidence-based practices focused on timely, intentional proactive device selection implemented within 24 hours of admission into any acute facility. VHP is an all-inclusive clinical pathway, guiding clinicians from device selection through patient discharge, including daily assessment. Initiation of the VHP programme within a facility provides a systematic pathway to improve vascular access selection and patient care, allowing for the reduction of variations and roadblocks in care while increasing positive patient outcomes and satisfaction. Patient safety and preservation of vessel health is the ultimate goal.

Entities:  

Mesh:

Year:  2012        PMID: 22307471      PMCID: PMC6159814          DOI: 10.5301/jva.5000042

Source DB:  PubMed          Journal:  J Vasc Access        ISSN: 1129-7298            Impact factor:   2.283


Vascular access for the infusion of medications and solutions requires timely assessment, planning, insertion, and assessment. Traditional vascular access is reactive, painful, and ineffective, often resulting in the exhaustion of peripheral veins prior to consideration of other access options. Evidence suggests clinical pathways improve outcomes by reducing variations and establishing processes to assess and coordinate care, minimizing fragmentation and cost. Implementation of a vascular access clinical pathway leads to the intentional selection of the best vascular access device for the patient specific to the individual diagnosis, treatment plan, current medical condition, and the patient's vessel health (1). The Vessel Health and Preservation (VHP) programme incorporates evidence-based practices focused on timely, intentional proactive device selection implemented within 24 hours of admission into any acute facility. VHP is an all-inclusive clinical pathway, guiding clinicians from device selection through patient discharge, including daily assessment. Initiation of the VHP programme within a facility provides a systematic pathway to improve vascular access selection and patient care, allowing for the reduction of variations and roadblocks in care while increasing positive patient outcomes and satisfaction. Patient safety and preservation of vessel health is the ultimate goal.
  20 in total

1.  Implementing a better bundle to achieve and sustain a zero central line-associated bloodstream infection rate.

Authors:  Timothy Royer
Journal:  J Infus Nurs       Date:  2010 Nov-Dec

Review 2.  Cost containment and infusion services.

Authors:  Kathy Kokotis
Journal:  J Infus Nurs       Date:  2005 May-Jun

3.  Preventing Clostridium difficile infections: an executive summary of the Association for Professionals in Infection Control and Epidemiology's elimination guide.

Authors:  Terri Rebmann; Ruth M Carrico
Journal:  Am J Infect Control       Date:  2011-03-03       Impact factor: 2.918

Review 4.  Peripherally inserted central venous catheters.

Authors:  M A Ryder
Journal:  Nurs Clin North Am       Date:  1993-12       Impact factor: 1.208

5.  The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU.

Authors:  David K Warren; Jeanne E Zack; Jennie L Mayfield; Alexander Chen; Donna Prentice; Victoria J Fraser; Marin H Kollef
Journal:  Chest       Date:  2004-11       Impact factor: 9.410

6.  Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care.

Authors:  P Eggimann; S Harbarth; M N Constantin; S Touveneau; J C Chevrolet; D Pittet
Journal:  Lancet       Date:  2000-05-27       Impact factor: 79.321

7.  Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

Authors:  Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein
Journal:  MMWR Recomm Rep       Date:  2002-08-09

8.  An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center.

Authors:  David K Warren; Jeanne E Zack; Michael J Cox; Max M Cohen; Victoria J Fraser
Journal:  Crit Care Med       Date:  2003-07       Impact factor: 7.598

9.  Reducing clinical variations with clinical pathways: do pathways work?

Authors:  M Panella; S Marchisio; F Di Stanislao
Journal:  Int J Qual Health Care       Date:  2003-12       Impact factor: 2.038

10.  Improving patient outcomes through CQI: vascular access planning.

Authors:  A J Barton; G Danek; P Johns; M Coons
Journal:  J Nurs Care Qual       Date:  1998-12       Impact factor: 1.597

View more
  14 in total

Review 1.  Reducing catheter-related thrombosis using a risk reduction tool centered on catheter to vessel ratio.

Authors:  Timothy R Spencer; Keegan J Mahoney
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

2.  Development of the UK Vessel Health and Preservation (VHP) framework: a multi-organisational collaborative.

Authors:  Carole Hallam; Valya Weston; Andrea Denton; Steve Hill; Andrew Bodenham; Helen Dunn; Tim Jackson
Journal:  J Infect Prev       Date:  2016-01-10

3.  Substantial harm associated with failure of chronic paediatric central venous access devices.

Authors:  Amanda J Ullman; Tricia Kleidon; Marie Cooke; Claire M Rickard
Journal:  BMJ Case Rep       Date:  2017-07-06

4.  Evaluation of Skin Colonisation And Placement of vascular access device Exit sites (ESCAPE Study).

Authors:  Nancy L Moureau; Nicole Marsh; Li Zhang; Michelle J Bauer; Emily Larsen; Gabor Mihala; Amanda Corley; India Lye; Marie Cooke; Claire M Rickard
Journal:  J Infect Prev       Date:  2018-11-09

5.  Vessel Health and Preservation Framework: Use of the outcome logic model for evaluation.

Authors:  Emma Burnett; Carole Hallam; Evonne T Curran; Valya Weston
Journal:  J Infect Prev       Date:  2017-11-27

6.  Development of a clinical prediction rule to improve peripheral intravenous cannulae first attempt success in the emergency department and reduce post insertion failure rates: the Vascular Access Decisions in the Emergency Room (VADER) study protocol.

Authors:  Peter J Carr; James C R Rippey; Marie L Cooke; Chrianna Bharat; Kevin Murray; Niall S Higgins; Aileen Foale; Claire M Rickard
Journal:  BMJ Open       Date:  2016-02-11       Impact factor: 2.692

7.  A clinical pathway for the management of difficult venous access.

Authors:  Vanno Sou; Craig McManus; Nicholas Mifflin; Steven A Frost; Julie Ale; Evan Alexandrou
Journal:  BMC Nurs       Date:  2017-11-17

8.  UK Vessel Health and Preservation (VHP) Framework: a commentary on the updated VHP 2020.

Authors:  Carole Hallam; Andrea Denton; Valya Weston; Helen Dunn; Tim Jackson; Susan Keeling; Steve Hill
Journal:  J Infect Prev       Date:  2020-12-14

Review 9.  Vascular access specialist teams for device insertion and prevention of failure.

Authors:  Peter J Carr; Niall S Higgins; Marie L Cooke; Gabor Mihala; Claire M Rickard
Journal:  Cochrane Database Syst Rev       Date:  2018-03-20

10.  Not "just" an intravenous line: Consumer perspectives on peripheral intravenous cannulation (PIVC). An international cross-sectional survey of 25 countries.

Authors:  Marie Cooke; Amanda J Ullman; Gillian Ray-Barruel; Marianne Wallis; Amanda Corley; Claire M Rickard
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.